+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psychosocial Aspects of Chronic Kidney Disease. Exploring the Impact of CKD, Dialysis, and Transplantation on Patients

  • Book

  • September 2020
  • Elsevier Science and Technology
  • ID: 5018788

Psychosocial Aspects of Chronic Kidney Disease: Exploring the Impact of CKD, Dialysis, and Transplantation on Patients provides an overview of the emotional and psychological challenges faced by people with renal disease. This book outlines the epidemiology and treatment of the psychosocial factors affecting them. The sections in the book cover psychiatric illness in the earlier and middle stages of chronic kidney disease, end-stage renal disease treated with dialysis, and renal transplantation. The book concludes with a section on special considerations, delving into topics such as treating children and adolescents, quality of life, caregiver burden, challenges in psychosocial research in kidney disease, and future directions for intervention.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Section I: Introduction
1. Introduction
Norman B. Levy
2. Coping With Chronic Illness: The Challenge of Patients with Renal Disease
Daniel Cukor, Scott D. Cohen and Paul L. Kimmel
3. The Landscape of Psychiatric Illness in CKD and ESRD
Alice Won and Paul L. Kimmel
4. Social Determinants of Racial and Socioeconomic Disparities in CKD and ESRD
Jenna M. Norton

Section II: Chronic Renal Disease
5. Psychological Challenges and Psychiatric Illness in Earlier Stages of CKD
L. Parker Gregg and S. Susan Hedayati
6. Physical Activity for Patients with CKD
Capri G. Foy

Section III: Patients with ESRD Treated with Dialysis
7. Depression in Patients with CKD and ESRD
David K. Quinn and Daniel Cukor
8. Anxiety in Patients with CKD and ESRD
Paul L. Kimmel, Scott D. Cohen and Daniel Cukor
9. Sleep Disorders in Patients with CKD and ESRD
Maria-Eleni Roumelioti, Christos P. Argyropoulos and Mark L. Unruh
10. Pain and Symptom Burden in Patients with CKD and ESRD
Manisha Jhamb and Jennifer Steel
11. Cognitive Functioning in Patients with CKD and ESRD
Konstadina Griva and Stanton P. Newman
12. Sexual Function in Patients with CKD and ESRD
Connie J. Wang, James B. Wetmore and Kirsten L. Johansen
13. Social Support in Patients with CKD and ESRD
Saad Alshihiri and Scott D. Cohen
14. Adherence and Illness Perceptions in Patients with CKD and ESRD
Joseph Chilcot, John Weinman and Ken Farrington
15. Psychiatric Challenges in Patients Treated with Peritoneal Dialysis
Susie Q. Lew and Patricia Centron
16. Palliative and End-of-Life Care in Patients with ESRD
Nathaniel Berman and Elly Varma

Section IV: Renal Transplantation
17. Psychosocial Evaluation in Kidney Transplantation
Kristy L. Engel and Kristin K. Kuntz
18. Psychiatric Challenges and Management in Kidney Transplantation
Matthew Christian Cornelius
19. Adherence Management in Transplantation
Sabina M. DeGeest, Janette Ribaut, Kris Denhaerynck and Fabienne Dobbels

Section V: Special Considerations
20. Pediatric and Adolescent Patients with CKD and ESRD
Kaushalendra Amatya, Marva M. Moxey-Mims and Stephen R. Hooper
21. Caregivers of People with Kidney Disease Melissa
S. Nataatmadja and Nicholas A. Gray
22. Measuring and Improving Quality of Life
C. Graham Ford, Mark L. Unruh and Larissa Myaskovsky
23. Challenges in Psychosocial Research in Renal Populations
Rajnish Mehrotra and Daniel Cukor
24. Future Directions for Psychiatric Intervention: Novel Models of Service Delivery
Daniel Cukor and Scott D. Cohen

Authors

Daniel Cukor Director, Behavioral Health, The Rogosin Institute, New York, NY, USA. Dr. Cukor is currently the Director of Behavioral Health at The Rogosin Institute in New York City, one of the premier centers for the study and management of kidney disease in the country. He received his Ph.D. in Clinical Health Psychology from Ferkauf Graduate School (2002) and has post graduate training in cognitive behavioral interventions. The bulk of his research has focused on psychosocial issues in patients with end stage renal disease. He has received grant support for his research from a variety of local and federal funding sources. His current interests are focused on depression, anxiety, sleep difficulty, pain, caregiver burden, and patient activation in patients with chronic kidney disease. Scott D. Cohen Division of Renal Diseases and Hypertension, Department of Medicine, George Washington University, Washington DC, United States. Associate Professor of Medicine, Division of Renal Diseases and Hypertension, George Washington University. Fellow of the American Society of Nephrology. Dr. Cohen's clinical interests include the treatment of glomerulonephritis, chronic kidney disease, acute kidney injury, hypertension, renal transplantation, and dialysis. His research interests include novel therapeutic options for the treatment of glomerulonephritis, and outcomes research in chronic kidney disease and acute kidney injury. Paul L. Kimmel Division of Renal Diseases and Hypertension, Department of Medicine, George Washington University, Washington, DC, United States. Paul L. Kimmel, MD, MACP, FRCP, FASN, was educated at Yale College and the New York University School of Medicine. He completed his internal medicine residency at Bellevue Hospital in New York City and Nephrology fellowship at the Hospital of the University of Pennsylvania. He was a member of the faculty at the University of Pennsylvania and the George Washington University, where he attained the rank of professor. From 2001 to 2006, Dr. Kimmel served as Director of the Division of Renal Diseases and Hypertension at George Washington University. From 2006 to 2008, he was the Director of Education of the American Society of Nephrology. Dr. Kimmel currently is Clinical Professor of Medicine at George Washington University in Washington, DC. His interests include psychosocial adaptation to chronic renal disease, sleep disorders in patients with kidney disease, zinc metabolism in renal diseases, HIV associated kidney diseases, the clinical genetics of common kidney disease, and the interrelationships between acute kidney injury and chronic kidney disease.